Discovery & Development Europe 2026
15 - 16 June 2026
Estrel Congress Centre, Berlin, Germany
Estrel Congress Centre, Berlin, Germany
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Discovery & Development Europe 2025: 23 - 24 June 2025, Basel, Switzerland
Andreas Gryczke
Director, Process Engineering,
AbbVie
Emma Mead
Chief Scientific Officer, Oxford Drug Discovery Institute,
University of Oxford
Heinrich Haas
Chief Technology Officer,
Neovacs
Karin Conde-Knape
Senior Vice President, Early Development,
Novo Nordisk
Morten Grunnet
Vice President, Head of Neuroscience ,
Lundbeck
Philippe Marc
Executive Director, Global Head of Integrated Data Sciences,
Novartis
Shadi Farhangrazi
Chief Executive Officer,
S.M. Discovery Group
Sorina Morar-Mitrica
Director Science & Technology,,
Novartis
Stephen Pham
Senior Vice President, Product Development,
Avalyn Pharma Inc.
Ulrich Betz
Senior Vice President Innovation,
Merck
Aaron Smith
Associate Director,
AstraZeneca
Abhishek Choudhary
Principal Data Engineer,
Bayer
Abi Heath
Patent Attorney & Counsel,
Kilburn & Strode
Alain Martelli
External Science Lead Europe, Discovery Network,
Pfizer
Alex Alderton
Senior Director of High Throughput Screening,
AstraZeneca
Amal Ali Elkordy
Professor,
University of Sunderland
Amardeep Singh Bhalla
Executive Director,
Regeneron
Andreas Bernkop Schnurch
Professor,
University of Innsbruck
Andrew Woodhead
Head of Chemistry,
Astex Pharmaceuticals
Andy Pike
DMPK Project Lead,
AstraZeneca
Antonia Stepan
Section Head - Medicinal Chemistry,
Roche
April Woulfe
Scientist,
Alchemab Theraputics Ltd
Schedl_quantro-tx.jpg?length=600&name=1a7420d5-7d72-4600-b14a-ead67fd7791c-2-11764368speaker_photo-039_20220601_(c)Schedl_quantro-tx.jpg)
Arianna Sabò
Head of Research & Discovery,
QUANTRO Therapeutics
Arne Skerra
Professor ,
Technische Universität München
Benedict Cross
CTO,
PhoreMost Ltd
Burkhard Schäfer
Managing Director & Director at SiLA,
SiLA
Cesare Spadoni
Co-Founder & Chief Operating Officer,
Oncoheroes Biosciences
Christine Maurer
Scientific Associate Director Biotransformation,
Merck Healthcare KGaA
Christoph Rösli
Director Research,
CSL Behring & BaseLaunch
Chuang Kee Ong
Director Data Product,
GSK
.jpg?length=600&name=e73c85c3-43f1-4040-a19a-58133b2c8d0e-2-11764368speaker_photo-KITZ_vanTILBURG-Cornelis_180502_2988-(6).jpg)
Cornelis Van Tilburg
Head of KiTZ CTU,
Hopp-Kindertumorzentrum Heidelberg
Covadonga Paneda
Chief Operating Officer,
Altamira Therapeutics
Daniel Tondera
Head of Biology,
Pantherna Therapeutics
David Jenkinson
Head of Childhood Cancer Translational Challenge,
LifeArc
David Dexter
Research Director,
Parkinson's UK
David Gnutt
Vice President, Complex In Vitro Lead, RED Cardiovascular, Renal and Immunology, ,
Bayer
Delphine Heenen
Kicker in Chief Managing Director,
KickCancer
Diana Knapp-Bühle
Associate Director and DMPK Lead,
Merck Healthcare KGaA
Eric Lorent
Senior Scientist,
Sanofi
Eva Aparicio
Product Owner,
Roche
Fabrizio Dissegna
Formulator,
Chiesi
Farshad Ramazani
Senior Expert Science & Technology ,
Novartis
Florian Ries
Senior Scientist,
AbbVie
Gergely Toth
Chief Executive & Scientific Officer, Founder,
Cantabio Pharmaceuticals
Giovanni Spagnolli
Chief Technology Officer,
Sibylla Biotech
Heena Khatter
Principal Scientist,
Roche
Ian Roberts
Senior Director, Digital Biology,
Healx
Iris Valtingojer
Sanofi Childhood Cancer R&D CSR Lead,
Sanofi
Jack Doolan
Principal Scientist,
GSK
James Love
Vice President, Cross Modalities Workflows,
Novo Nordisk
James Connell
Scientific Director - Translational Matrix Group,
LifeArc
Jens Twellmeyer
Associate Director Science & Technology,
Novartis
Jens Frauenfeld
Chief Executive Officer,
Salipro Biotech
Joao Seixas
CEO,
TargTex
Johanna Roostalu
Director, Therapeutics, Venture Creation,
BioInnovation Institute
Jonathan Hopper
Vice President, Platforms & Founder,
OMass Therapeutics
Jörg Berghausen
Associate Director,
Novartis
Jose-Carlos Gomez-Tamayo
Senior Scientist II,
Janssen Pharmaceutical Companies of Johnson & Johnson
Juan-Carlos Sanchez
Partner,
Woxsen University
Kamalinder Singh
Professor of Pharmaceutical Technology & Drug Delivery,
University of Central Lancashire
Karsten Maeder
Professor,
Martin Luther University Halle-Wittenberg
Katja Petkau Milroy
Formulation Scientiest,
Microsol
Kelly Zalocusky
Senior Director of Computational Biology, Neuroscience ,
Recursion Pharmaceuticals
Knut Biber
Research Fellow & Head of Glial Biology Team,
AbbVie
Konstantinos Gkatzis
Head,
Ksilink
Kristina Levan
Business Developer,
Business Region Gothenburg
Krisztian Kaszas
Principal Scientist,
Johnson & Johnson
Lars van der Veen
Chief Scientific Officer,
ionctura
Laura Gasparini
Director -Tau pathobiology,
AbbVie
Lene Gerlach
Venture Partner; Founder & Chairperson,
Hadean Ventures; Women in Life Science Denmark
Maeve Caldwell
Professor in Neuroscience, Physiology,
Trinity College Dublin
Manuela Cerina
Scientific Director of Neurodegeneration,
LifeArc
.jpg?length=600&name=1331ca3f-d428-4603-8c2e-f580543806cd-2-11764368speaker_photo-E4E7916C-3A57-465C-93C7-31BC36FB8F34-(1).jpg)
Marcos Costa
Principal Scientist,
Roche
Maria Levitin
Director of RNA Oligonucleotide Delivery, Genetic Medicine,
Grünenthal GmbH
.jpg?length=600&name=bf0f9a64-4ef1-48c0-a59b-cf12aabf7598-2-11764368speaker_photo-20250203_102420-(1).jpg)
Marie-Christine Pardon
Assistant Professor in Translational Neuroscience,
University of Nottingham
Marius Lutz
Scientist, Process Chemistry,
Hoffmann La Roche Ltd
Mark Chiu
President & Chief Scientific Officer,
Tavotek BioTherapeutics
Markus Hierl
Principal Associate,
Hoffmann La Roche Ltd
Martinus Capelle
Distinguished Scientist II,
Johnson & Johnson Innovative Medicine
Meike Harms
Lead Scientist,
Merck
Meiling Li
Principal Scientist,
Roche
Michael Johnson
Professor of Neurology and Genomic Medicine,
Imperial College London
Miroslav Cik
Senior Principal Research Scientist,
Abbvie
Moein Moghimi
Professor of Nanomedicine and Pharmaceutics,
School of Pharmacy at Newcastle University
Naisha Shah
Vice President of Data Science,
BioAge Labs
Peng Leong
CBO and Head of Brain Aging,
Bioage labs
Phil Noble
Head of Single B Cell Antibody Discovery,
UCB Pharma
Philip Hewitt
Global Head of Early Investigative Toxicology,
Merck
Rainer Wilcken
Senior Director, Computational Chemistry,
Flare Therapeutics Inc
Ramesh Kashi
Former Senior Scientific Director,
Bristol Myers Squibb
Rick Ewing
VP, Head of Chemistry,
Rapafusyn
Roderick Beijersbergen
Head of NKI Genomics Core Facility & Professor of Functional Genomics,
The Netherlands Cancer Institute & University of Amsterdam
Sabine Kuratli
CMC Lead,
CEPI
.jpg?length=600&name=5d9d5049-7369-4b94-97b4-06cd49798ce9-2-11764368speaker_photo-Sagar-pic-Image-(2).jpg)
Sagar Chandekar
Senior Medical Director, Alzheimer's Disease,
Novo Nordisk
Sam Daems
Researcher, I3h (ULB) & Portfolio Principal,
Waterland Private Equity
Sandor Batkai
Life Science Consultant, Former, Head of Medical Research and Intelligence,
Formerly Cardior Pharmaceuticals
Sarah Jolly
Principal Scientist,
LifeArc
Simone Hornemann
Director UZH CRISPR Screening Hub,
University of Zurich
Sophie Janbon
Director,
AstraZeneca
Steen Krogsgaard
Scientific Automation Director,
Novo Nordisk
Stefan Schiesser
Director of Medicinal Chemistry,
AstraZeneca
Stefano Romanelli
Senior Government Affairs Manager,
EUCOPE
Stephanie Harlfinger
Senior Director, Global Head NCE DMPK,
Merck & Cie KmG
Supriyadi Hafiz
Senior Scientist,
Merck
Suruchi Vishwasrao
Senior Scientist,
Merck Life Science Pvt. Ltd.
Sven Verguts
Associate Director, Emerging Biotech & ATMPs,
Merck
Tamara Maes
Former Chief Scientific Officer & Founder,
Oryzon Genomics
Tanvir Tabish
Director,
Astrazeneca
Thanneer Malai Perumal
Senior Principal Scientist,
Hoffmann La Roche Ltd
Tjasa Vrlinic
Principal Investigator,
Medincell
Tom Kissling
pRED Automation Partner & Director at SiLA,
F. Hoffmann-La Roche AG
Tomasz Ratajczak
Formulation Expert,
Polpharma
-For-Web_00014-(1).jpeg?length=600&name=87a22798-6486-4caf-9641-7591cee861af-2-11764368speaker_photo-2025_01_06_KQ_Labs_JPEG-8-bit-300ppi-(sRGB)-For-Web_00014-(1).jpeg)
Toria Legh-Land
Computational Pharmaceutics Lead,
Microsol
Trond Ulven
Professor,
Copenhagen University
Valentina Romeo
Principal Scientist & Group Leader,
Roche
Vik Reebye
Head of Academic Partnerships ,
MiNA Therapeutics Ltd
Virginia Ballotta
New Ventures Manager,
BaseLaunch
Vladimir Talibov
Associate Principal Scientist,
Sprint Bioscience
Xavier Garrabou
Director of Operations,
Vivtex
Yi Sun
Associate Professor,
Technical University of Denmark
Zeeshan Ahmad
Reader in Pharmaceutics and Drug Delivery,
University of Manchester
Zhi Yao
Principal Scientist,
LifeArc
Zhizhou Fang
Associate Scientific Director,
Merck Healthcare KGaA
Zoran Rankovic
Professor of Chemical Biology & Director, Centre for Protein Degradation,
The Institute of Cancer Research
Meet Our Esteemed Sponsors
Platinum Sponsors
10x Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Bruker Spatial Biology
Platinum Sponsor
Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology.
The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity.
Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing.
For more information, visit www.BrukerSpatialBiology.com.
Gold Sponsors
ariadne.ai
Gold Sponsor
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
Cell Signaling Technology
Gold Sponsor
CST® is a privately-owned, global company headquartered in Danvers, Mass., USA. Founded in 1999 and still led by research scientists. We are actively engaged in the development of products and technologies that facilitate signaling analysis and mechanistic cell biology and cancer research.
Miltenyi Biotec, Ltd.
Gold Sponsor
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.
Quantum-Si
Gold Sponsor
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Singular Genomics
Gold Sponsor
Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues
Vizgen
Gold Sponsor
Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Vizgen is headquartered in Cambridge, Massachusetts, and can be found online at www.vizgen.com and www.ultivue.com. Connect on social media Twitter, LinkedIn and Facebook.
Silver Sponsors
ACD, Bio-Techne
Silver Sponsor
ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine.
Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily.
Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.
Ardigen S.A.
Silver Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Complete Genomics
Silver Sponsor
Complete Genomics is a pioneering life sciences company offering innovative, comprehensive sequencing solutions, including sample/library preparation, lab automation, sequencing, and data analysis. Our sequencing portfolio features a full range of sequencers designed to meet low, medium, and high throughput needs, all powered by our proprietary DNBSEQ technology. To date, over 9,700 publications have utilized DNBSEQ technology across a broad spectrum of applications.
As the exclusive distributor of STOmics products in North America, Complete Genomics provides access to Stereo-seq technology—the only spatial transcriptomics solution worldwide capable of exploring the entire transcriptome at true single-cell resolution.
To learn more, visit https://www.completegenomics.com
GENEWIZ from Azenta Life Sciences
Silver Sponsor
As a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Hamilton
Silver Sponsor
Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs.
Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada;Franklin, Massachusetts;Timișoara, Romania;Bonaduz, Switzerland;and subsidiary offices throughout the world.
Lunaphore Technologies SA, a Bio-Techne company
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Navinci
Silver Sponsor
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
NeoGenomics Laboratories
Silver Sponsor
NeoGenomics is a premier cancer diagnostics company, specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. We partner with pharmaceutical clients from discovery to commercialization with broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
Parse Biosciences
Silver Sponsor
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Sapient Bioanalytics
Silver Sponsor
Sapient is a leader in multi-omics discovery, providing bespoke services for proteomics, metabolomics, lipidomics data generation and delivering insights that enable biopharma sponsors to go beyond the genome to accelerate precision drug development.
Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping and integrative analyses with other omics and real-world data.
Aided by our proprietary Human Biology Database — comprising data from tens of thousands of samples in which we can mine for and validate biomarkers and targets — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.
Scale Biosciences
Silver Sponsor
Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
Single Cell Discoveries
Silver Sponsor
Single Cell Discoveries is a Contract Research Organization (CRO) specializing in innovative single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics. Single Cell Discoveries delivers high-impact insights to biopharmaceutical companies, healthcare systems, and academic research centers worldwide. Single Cell Discoveries' mission is to accelerate groundbreaking research by developing and providing state-of-the-art single-cell technologies as a service.
.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Bronze Sponsors
Aspect Analytics
Bronze Sponsor
Aspect Analytics develops enterprise software to analyze and integrate spatial omics data. Spatial technologies are steadily maturing into a key enabler in drug development, biomarker discovery, and life science research. With spatial omics datasets commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology. Aspect Analytics bridges the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key spatial omics-based applications. Our software can (i) extract maximal knowledge from spatial data, including co-registration with different modalities, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing spatial multi-omics data into a single view, collaborative platform.
Atrandi Biosciences
Bronze Sponsor
Atrandi Biosciences is a pioneering life sciences tool company transforming single-cell analysis with Semi-Permeable Capsule (SPC) technology. SPCs redefine how single-cell research is done, enabling multi-step, high-throughput workflows while maintaining true single-cell resolution. Unlike conventional methods, SPCs allow researchers to perform multiomic assays seamlessly, unlocking deeper insights into biology. Founded by leading scientists and driven by a mission to simplify research and advance discovery, Atrandi is shaping the future of single-cell analysis and empowering scientists worldwide.
Beckman Coulter
Bronze Sponsor
We are a life sciences company that provides an extensive portfolio of solutions for workflow innovation, lab automation of routine tasks/complex methods, and software solutions to advance your research.
Our lab automation solutions and genomic reagents portfolio facilitate seamless processes for DNA/RNA clean-up, size selection, extraction, and sample preparation for NGS, RNA-seq, and single-cell transcriptomics. By integrating our advanced solutions into your lab, you can achieve high-quality, reproducible data, empowering your AI and machine learning models.
Becton Dickinson Biosciences
Bronze Sponsor
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because we’ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare. For more information, please visit: www.bdbiosciences.com
CS Genetics
Bronze Sponsor
CS Genetics delivers simplicity in a world of complex, time-consuming and expensive single cell genomics workflows. Our nimble, experienced team understands that tomorrow’s discoveries require technology that is simple to adopt and easy to use with near-limitless scalability.
Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, Kinetic Confinement assay that plugs seamlessly into any molecular biology laboratory. This simplicity also enables an affordable price point so researchers will no longer have to limit the scale of their studies.
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
Hawk Biosystems
Bronze Sponsor
HAWK Biosystems is an innovative biotechnology company based in Bilbao, Spain, and a spin-off from prestigious institutions such as Cancer Research UK (CRUK) and the Francis Crick Institute in London. Founded in 2018 by an exceptional team of scientists and business leaders, HAWK has rapidly positioned itself at the forefront of spatial biology, providing ground-breaking solutions for the analysis of protein functions in tissue.
At HAWK Biosystems, our mission is to develop advanced diagnostic systems that accelerate the progress of personalized medicine, focusing on critical diseases such as cancer. Our cutting-edge technology, QF-Pro®, is a revolutionary platform that enables precise, quantitative analysis of protein functions at a sub-pixel resolution. Unlike traditional techniques, QF-Pro® is capable of identifying protein-protein interactions and post-translational modifications within tissue samples at a resolution of less than 10 nanometers. This innovation provides clinicians and researchers with reproducible, robust, and unbiased data, which has demonstrated significant clinical value. For instance, QF-Pro® has been validated in a study to predict patient response to PD-1/PD-L1 inhibitors in lung cancer, demonstrating its potential to significantly improve treatment outcomes by potentially tripling response rates and doubling survival rates.
Leica Microsystems & Leica Biosystems
Bronze Sponsor
Leica Microsystems develops and manufactures microscopes and scientific instruments for
the analysis of microstructures and nanostructures. Widely recognized for optical precision
and innovative technology, the company is one of the market leaders in compound and stereo
microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy.
Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Levitasbio
Bronze Sponsor
LevitasBio is dedicated to advancing science and
human health by providing researchers with new
and powerful methods for sample preparation and
characterization. The LeviCell platform is a
first-in-class cell enrichment solution powered
by a proprietary, label-free, and gentle Levitation
Technology. Our unique solution generates
high-quality samples while preserving the cells’
native state, enabling researchers across multiple
scientific disciplines to uncover true biology.
Accelerate Scientific Discovery With the Power of
Levitation Technology
.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png){kind=logo}
RareCyte
Bronze Sponsor
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Zifo Technologies
Bronze Sponsor
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and qualit
Network & Programme Sponsors
Aliri Bioanalysis
Network & Programme Sponsor
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
.svg){kind=logo}
BioLizard
Network & Programme Sponsor
At BioLizard, we “think data” and “speak biology”, partnering with our clients to transform lives. Our expert team combines deep biological knowledge with cutting-edge AI and bioinformatics to tackle complex data challenges in human and animal health. Through our AI-native Bio|Verse platform, we accelerate biomarker discovery and enable actionable insights for modern drug development. With a global presence, we deliver tailored solutions in data management, bioinformatics, and AI to drive your data-driven strategy to biotech, pharma and diagnostic companies. Let’s shape the future of life sciences together—connect with BioLizard today!
.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png){kind=logo}
Discovery Life Sciences
Network & Programme Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png){kind=logo}
Elucidate Biotechnologies
Network & Programme Sponsor
Elucidate Bio provides multi-modal spatial biology services, enabling same-tissue imaging of DNA, RNA, and protein with single-cell spatial resolution. Powered by technology licensed from Sizun Jiang at Harvard Medical School/BIDMC, we specialize in single-slide spatial proteomic, transcriptomic, and genomic data
generation and analysis. With rigorous quality control, we deliver high-quality data, detailed analysis, and actionable insights to advance biomarker discovery, therapeutic development, and precision medicine. Contact Elucidate Bio to explore innovative spatial pipelines tailored to your program needs.
Psomagen
Network & Programme Sponsor
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Scailyte
Network & Programme Sponsor
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio.
The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in various clinical projects in immunology and oncology.
.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)
Stellaromics
Network & Programme Sponsor
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.
The Stellaromics Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples at an unprecedented resolution. These breakthroughs, based on the company's STARmap and RIBOmap technologies, greatly expand upon applications of traditional 2D methods by offering a true 3D perspective, providing researchers with a deeper understanding of tissue organization, cellular interactions, and disease mechanisms.
Via Scientific
Network & Programme Sponsor
Via Scientific: AI-Powered Acceleration for Multi-Omics & Spatial Biology
AI-Driven Bioinformatics Innovation: Via Foundry, Via Scientific’s AI-powered platform, accelerates multi-omics research by eliminating bioinformatics bottlenecks. It enables research teams to build custom analysis pipelines without coding, automating data processing so scientists can focus on discovery. Foundry acts as a “force multiplier” for biomedical research, dramatically reducing time to insights.
Unified Multi-Omics & Spatial Insights: Designed for multi-omics and spatial biology, Via Foundry integrates genomics, transcriptomics, proteomics, and spatial data into a single platform. This fusion reveals deep biological insights missed by siloed analyses. With advanced visualization tools, Foundry handles large, complex datasets—accelerating discovery and development.
Empowering Next-Gen Research Collaboration: Built by scientists for scientists, Via Foundry upholds rigorous standards while enabling seamless collaboration across teams and long-term studies. With flexible deployment in the cloud or on-premises, it is trusted across academia, biotech, pharma, and healthcare. Combining AI-driven technology with an intuitive design, Via Scientific empowers researchers to unlock insights faster, more reliably, and at scale.
Visiopharm
Network & Programme Sponsor
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows.
Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Washington University
Network & Programme Sponsor
The McDonnell Genome Institute integrates cutting-edge ‘omics technologies and over 30 years of expertise to support your needs as your trusted partner. Explore our comprehensive solutions, including NGS, gene editing, stem cell biology, proteomics, and high-content imaging — custom-tailored to advance your research.
Start-Ups
Who Sponsored Discovery & Development Europe 2025?
Platinum Sponsors
Lonza (CHI division)
Platinum Sponsor
Lonza Capsules & Health Ingredients is a global leader in capsule design, manufacturing, and encapsulation technology, dedicated to creating tailored solutions that help you deliver groundbreaking health products to market. Our commitment to innovation empowers pharmaceutical and nutraceutical companies with high-quality products tailored to meet evolving market demands. As the proud provider of Capsugel® capsules, we offer an extensive portfolio that includes a wide range of hard empty capsules—both gelatin and plant-based—designed to optimize bioavailability and enhance product performance. Our innovation hub, Innovaform™ Accelerator, further enhances our capabilities by providing tailored formulation and encapsulation strategies that support clients throughout the entire development lifecycle.
Lonza Advanced Synthesis
Platinum Sponsor
Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of approximately 18,500 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. We support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.
In Advanced Synthesis, we apply more than 125 years’ expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates.
XtalPi
Platinum Sponsor
XtalPi is an innovative research platform company powered by artificial intelligence (AI) and robotics. Established in 2015 by three postdoctoral physicists at MIT, XtalPi is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. XtalPi combines quantum physics, AI, cloud computing, and large-scale robotics to provide R&D solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and advanced materials industries globally.
Gold Sponsors
Advanced Instruments
Gold Sponsor
Advanced Instruments is a global provider of scientific and analytical solutions for the biopharma and clinical industries.
Our company’s innovations have helped organizations improve quality, achieve reliable outcomes, and increase productivity for more than 70 years.
Our focus on service, quality, and reliability has made us a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries. Our newest addition, the Artel portfolio, includes leading analytical instruments, software and services that validate, automate, and calibrate critical liquid handling processes and instrumentation. Our Solentim portfolio delivers best-in-class imaging and single-cell deposition technologies for cell line development workflows. And our OsmoTECH® and OsmoPRO® micro-osmometers support the workflows that labs worldwide rely on for the delivery of accurate and timely results.
BioDuro-Sundia
Gold Sponsor
BioDuro is a US company founded in 1996, and headquartered in Irvine, California. With more than 2,000+ scientists, we have 7 R&D and manufacturing campuses across the US and China. We offer fully integrated CRDMO services from discovery to commercial manufacturing across medicinal chemistry, biology, DMPK, drug substance and drug product, including multiple modalities small molecules, peptides, oligonucleotides and antibody drug conjugates.
We leverage our broad capabilities and unique technology platforms to empower biotech and pharmaceutical partners worldwide. Our integrated approaches accelerate and de-risk new drug discovery and development, creating higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, innovative and people-focused culture.
As a pure-play CRDMO, BioDuro operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.
bit.bio
Gold Sponsor
bit.bio designs and manufactures human cells to advance drug discovery and biomedical research enabling transformative treatments in human health. Using our proprietary deterministic cell programming technology, opti-ox, we convert induced pluripotent stem cells (iPSCs) into any desired human cell type in a single step. Our AI powered discovery platform identifies unique combinations of transcription factors that can program any desired cell type with exceptional purity and consistency at scale, with products ready to ship globally. To date, bit.bio’s ioCells portfolio features 45 products, including ioWild Type Cells, ioDisease Model Cells, and ioCRISPR-Ready Cells.
Since spinning out from the University of Cambridge and launching in 2016, we have raised approximately $225m from leading investors, including Arch Venture, Blueyard Capital, Charles River Laboratories, Foresite Capital, M&G, Milky Way, National Resilience, and Tencent.
Causaly Ltd
Gold Sponsor
Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development.
Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.
.png?length=600&name=0bfa374f-caeb-4bd5-9f24-9b176c56bb3b-2-5668375logo-Pharmaron-Logo-High-Resolution-(4).png){kind=logo}
Pharmaron UK Ltd
Gold Sponsor
Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 19,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
Sai Life Sciences
Gold Sponsor
For 25 years, Sai Life Sciences has been a trusted partner in bringing new medicines to life, fast. As a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), Sai Life Sciences works with innovator biotech and pharma companies to accelerate the discovery, development and commercialization of complex small molecules. With 2850 employees across facilities in India, UK and USA, Sai supports innovators through journey from concept to commercialisation, including exploratory biology, creative chemistry, DMPK, toxicology, developability & formulations, early phase development, process & analytical development, scale-up, tech transfer, clinical supplies and cGMP manufacturing. Taking a nimble and creative approach, Sai delivers high-quality, cost-effective solutions to accelerate the time to market.
SciSure (formerly eLabNext)
Gold Sponsor
SciSure is transforming scientific organizations by creating a unified platform that eliminates silos and enhances collaboration. Our Scientific Management Platform (SMP) combines technology and expertise to boost efficiency, precision, and reproducibility in research.
With SciSure, you can:
Document experiments with our ELN
Manage samples and inventory using LIMS
Ensure safety with our EHS platform
Integrate your favourite tools through our Marketplace
Our mission is to streamline lab operations and accelerate scientific discovery by connecting data and empowering researchers.
Silver Sponsors
Alithea Genomics
Silver Sponsor
Alithea Genomics is a global leader in scalable transcriptomics solutions for screening applications.
We work with pharma, biotech and agrochemical clients to boost and de-risk their compound selection efforts.
Our high throughput and ultra-low cost library preparation technologies (DRUG-seq) enable RNA-seq data to be generated from several thousands samples in a convenient and streamlined solutions.
Our pipeline does not require RNA extraction and has been validated on several cell lines and organoid types.
On the data analysis side, we provide default upstream, downstream and QC analysis but we also provide bespoke solutions via our team of bioinformatic experts.
In addition to library preparation, sequencing and data analysis, we provide end-to-end and very high-throughput cell culture, treatment and imaging services (cell painting).
Aurigene Pharmaceutical Services
Silver Sponsor
Aurigene Pharmaceutical Services offers end-to-end discovery solutions to support the early stages of drug development, from hit identification to lead optimization and candidate nomination. With deep expertise in medicinal chemistry, in vitro and in vivo biology, DMPK, and biotherapeutics discovery, our multidisciplinary teams work seamlessly to accelerate timelines and enhance decision-making. Leveraging cutting-edge technologies, data-driven insights, and a collaborative approach, we enable global biotech and pharmaceutical partners to advance their discovery programs with speed and scientific precision. We also offer integrated API, intermediate, and formulation services that span key starting materials, advanced intermediates, and APIs to finished products such as oral solids, sterile products, nasal solutions, etc.
Axxam
Silver Sponsor
Axxam provides integrated early discovery services and solutions across the life sciences industry. We support pharmaceutical and biotech companies, start-ups, patient foundations, and academic groups in their journey from target assessment to lead optimization across all therapeutic areas and target classes. Axxam’s services comprise assay development, hit identification, including high-throughput screening, and hit-to-lead activities.
BDD Pharma
Silver Sponsor
BDD is an integrated CDMO/CRO with over 25 years experience in drug delivery, GMP manufacture, and early clinical testing.
Our formulation capabilities span from simple capsule/tablet dosage forms for rapid clinical evaluation to complex modified-release profiles using techniques like hot melt extrusion and our proprietary technologies – OralogiK™ and CologiK™.
OralogiK™ is a timed-release platform that can deliver drugs, or combinations of drugs, at predetermined times post-dosing, enabling the most complex profiles to be achieved. CologiK™ is an extension of the OralogiK™ platform that enables delivery of APIs to the colon for localised treatments or to avoid release in the stomach or small intestine. Both technologies have been proven clinically with a range of different APIs, from small molecules to biologics.
BDD’s product design strategies are underpinned by our unique understanding of biopharmaceutics, gained through years of clinical visualisation of product performance in humans using our Gamma Scintigraphic imaging capabilities.
Through our Lean Clinical Development™ pathway, we streamline the traditional early clinical development approach. We combine formulation development with “just in time” small scale clinical manufacturing, and Phase 1 testing to provide our clients with the fastest path to Phase 1 clinical data.
ChemAxon
Silver Sponsor
Chemaxon is a leading cheminformatics company providing software solutions for property calculation and molecule design, chemical drawing, chemical search and compound data management.
Certara acquired Chemaxon in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines. Together we help you innovate with confidence by turning your discovery process into a competitive advantage.
• Chemaxon’s universal chemical drawing tool serves the needs of research scientists and gives them access to our industry-standard chemical intelligence.
• Our solutions support the creation of new molecule design ideas and enable medicinal chemists to utilize advanced computational techniques and visualize their data.
• We support the standardization of chemical information to improve the quality of training data for AI models and scale your search to the range of hundreds of millions – billions of chemical structures.
Concept Life Sciences
Silver Sponsor
Concept Life Sciences is a UK-based drug discovery CRO , helping global pharma and biotech companies accelerate their drug candidate to clinic by offering integrated drug discovery programs as well as high quality solutions in Biology, Chemistry, ADME/ DMPK, Toxicology and GMP manufacturing. Concept Life Sciences has helped pharma and biotech companies accelerate 30 candidates to preclinical stage, 21 candidates to clinic, and 4 candidates to market.
Croda Pharma
Silver Sponsor
Croda Pharma and Avanti Research stand at the forefront of pharmaceutical innovation, specialising in the development of high purity materials for advanced drug formulations. Our expertise spans high purity excipients, protein delivery, bioprocessing ingredients, innovative lipids, and vaccine adjuvant excellence. By leveraging our extensive knowledge and cutting-edge technologies, we enable next-generation drug delivery solutions that cater to both human and animal health markets, delivered quickly and at scale. Our unique supply capabilities can support you from early research to large-scale, commercial production. Our pharmaceutical portfolio is unmatched in its quality and effectiveness, ensuring that we meet the most stringent industry standards.
HUB Organoids
Silver Sponsor
HUB Organoids BV is a pioneering biotechnology company specializing in the application of Organoid Technology to drug discovery, personalized medicine, and disease modeling. Founded in 2013 following the discovery of adult stem cells, HUB´s drug development platform uses advanced 3D organoid models derived from patient tissues, enabling more accurate and predictive research for preclinical testing and therapeutic development. HUB´s innovative platform accelerates the discovery of effective treatments by closely mimicking human biology and is available on a fee for service basis to scientists working in drug discovery and development in the therapeutic areas of oncology, inflammation/IBD, infectious diseases, and for toxicology investigation. HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany
IRBM
Silver Sponsor
IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate.
With a history of contributing to several approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields.
For further information, please contact us: bd@irbm.com
Website: https://www.irbm.com/
NanoFCM
Silver Sponsor
NanoFCM provides a versatile and powerful platform - Flow NanoAnalyzer for the multiparameter analysis of functional nanoparticles (7-500 nm) at single-particle level which has the capacity to measure the size, concentration, and biological properties of nanoparticles. To our knowledge, Flow NanoAnalyzer is the only flow cytometry instrument that covers the size range of exosomes (30-120 nm). Flow NanoAnalyzer is expected to become a powerful tool for life science, nanoscience and nanotechnology studies.
Flow NanoAnalyzer can be used for the characterization of extracellular vesicles(EVs), viruses, bacteria, and other natural biological nanoparticles as well as functional nanoparticles, which opens up a window to the nano-world for flow technology. By means of high-selectivity, high-resolution and high-throughput detection of the particle size, concentration, and biochemical properties of a single nanoparticles (7-1000 nm).
Nuvisan ICB GmbH
Silver Sponsor
Your partner of choice in bringing therapeutics to life
Nuvisan is a full-service contract research organisation (CRO) and development and manufacturing organisation (CDMO) with state-of-the-art laboratories in Germany and France.
Our pharmaceutical, biotechnology, venture capital and non-profit clients partner with us because our high-quality end-to-end solutions and scientific expertise enable us to streamline and accelerate drug discovery and development – from ensuring target understanding to helping bring therapeutics to life.
Founded over 40 years ago by a team of pharma industry innovators, Nuvisan has established a reputation for expertise and professionalism. Our team leaders have extensive experience in the biopharma industry, and our unique centres of excellence – for drug discovery in Berlin, formulation and GMP manufacturing in Sophia Antipolis, and our bioanalysis hub in Neu-Ulm – enable our experienced scientists to help guide and advance projects. We know how to discover, develop and bring the next generation of medicines to market. At the same time, we are committed to flexibility, transparency and collaboration in our approach, working closely with you to adapt to your individual needs, minimise risks and help deliver your project.
Optibrium
Silver Sponsor
Optibrium develops exceptional software and AI solutions that help scientists advance their discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the chemistry discovery process and supports a worldwide customer base, including leading pharma, biotech, agrochemical and flavouring companies and not-for-profit and academic groups.
Pfanstiehl GmbH
Silver Sponsor
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose, Tris base and Tris HCl and Amino Acids such as L-Arginine.L-Methionine and Histidine for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
RedShift BioAnalytics Inc
Silver Sponsor
RedShiftBio has developed a proprietary infrared platform based on Microfluidic Modulation Spectroscopy (MMS). This technology provides ultra-sensitive and ultra-precise measurements of molecular structure. Our rapid and fully automated Aurora TX system utilizes a 96-well plate, 50ul of sample, and provides both structure as well as stability, measured with thermal ramping, for your RNA, DNA, proteins, and peptides. Our instrumentation and software solutions are backed by a global network of sales, applications, service, and support teams to address all market needs.
Schrodinger
Silver Sponsor
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.
Secoya Technologies
Silver Sponsor
Secoya is a company based in Louvain-La-Neuve (Belgium) offering innovative solutions & equipment in particles engineering (Microfluidics) to the (bio)pharmaceutical industry from lab to industrial scale . At Secoya Technologies, our experts in Microfluidic develop technologies and equipment by a smart use of micro-structured elements, enabling a faster, precise and secure development and production process. The company has unique expertise in crystallisation, emulsification/encapsulation , pervaporation, process intensification and conjugation.
Secoya provides to the pharmaceutical industry technical solutions to production problems by developing tightly controlled processes and related industrial equipment. Our principle is to downscale the reactor to the ideal size to optimize such processes. Fields of expertise cover the crystallization of ingredients, chemical synthesis, micro-particle production, encapsulation and pervaporation.
Sever Pharma Solutions
Silver Sponsor
Sever Pharma Solutions is a full-service Contract Development & Manufacturing Organization (CDMO) for the development and production of advanced Polymer Drug Products and associated packaging services handling high-potent APIs within all segments of our expertise. In the polymer field we are providing high end development with a clear focus towards cost efficient supply of high-value products. Our polymer and extrusion experts will help you develop polymer-based delivery systems that can be produced robustly against affordable costs at any scale.
We have CMO capacity available for aseptic filling of syringes (PFS) and if requested also assembly and packaging of pre-filled syringes and auto-injectors. All made in fully automated manufacturing lines with capacity and capability to handle volumes from smaller amounts needed for clinical trials (CTM) up to commercial volumes up to 8 million syringes annually.
Capabilities
We are a specialized CDMO and we can handle High-Potent APIs within all capabilities.
CAPABILITIES
Polymer Delivery Systems. In the polymer field we are providing high end development with a clear focus towards cost efficient supply of high-value products, using injection molding and extrusion in the most optimal way.
Hot Melt Extrusion. Our extrusion experts will help you develop polymer-based delivery systems with a clearly defined extrusion manufacturing process to meet your needs in solvability. The manufacturing process will be optimized to be robust enabling affordable costs at any scale.
Aseptic pre filled syringes and autoinjectors. PFS. SHL. We have CMO capacity available for aseptic filling of syringes (PFS) and if requested also assembly and packaging of pre-filled syringes and auto-injectors. All made in fully automated manufacturing lines with capacity and capability to handle volumes from smaller amounts needed
Symeres
Silver Sponsor
Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges.
With over 600 highly educated scientists in six locations in Europe and two in the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.
Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API.
WuXi AppTec, UK Ltd
Silver Sponsor
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec's integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
Bronze Sponsors
Captisol
Bronze Sponsor
Captisol is a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY® (remdesivir) and KYPROLIS®️ (carfilzomib) to help solubilize & stabilize difficult to deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency.
Cell Signaling Technology
Bronze Sponsor
Doing good science is important. So is just doing good.
Cell Signaling Technology (CST) is a different kind of life science company—one founded, owned, and led by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor for over 20 years. We consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery. Founded in 1999 and headquartered in Danvers, Massachusetts, USA, CST employs over 600 people worldwide.
Helping researchers find new solutions is our main mission every day—but it’s not our only mission. We’re also dedicated to helping identify solutions to other problems facing our world. We believe that all businesses must be responsible and work in partnership with local communities, while seeking to minimize their environmental impact. That’s why we joined 1% for the Planet as its first life science member, and have committed to achieving net-zero emissions by 2029.
At CST, we believe in the power and promise of science to solve the challenges we face as a global community. We’re a company of caring people driven by a devotion to facilitating good science—a company committed to doing the right thing for our Customers, our communities, and our planet.
.jpg?length=600&name=61ac7f24-46f1-4373-9564-8293c215c0a7-2-5668375logo-CDDV_L_BLUE_ON_WHITE_CMYK-(9).jpg)
Collaborative Drug Discovery
Bronze Sponsor
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by creative biologists and chemists working in academic, biotechnology and pharmaceutical settings. Their flagship product, CDD Vault, enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a straightforward web interface. CDD Vault helps scientists register entities, track inventory, manage bioassay data, capture experiments, calculate Structure-Activity Relationships (SAR), and mine their data for drug candidates. It also functions as an Electronic Laboratory Notebook (ELN) to capture and share experimental results. CDD Vault is differentiated through its intuitive design, superior performance, and workflows for secure, collaborative data sharing capabilities. CDD was founded in 2004 and presently serves thousands of researchers doing drug discovery all around the world. Learn more at www.collaborativedrug.com
Element Biosciences
Bronze Sponsor
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com and follow us on LinkedIn, X (Twitter), and Facebook.
Evonik
Bronze Sponsor
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.2 billion and an operating profit (adjusted EBITDA) of €2,1 billion in 2024. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.
Evonik’s Health Care business line is a global innovation hub for the world’s leading life science companies from the pharmaceutical, nutraceutical and medical device industries.
We support customers along the entire product cycle from early development to commercial manufacturing. Our system solutions are backed by the scientific excellence of our interdisciplinary and diverse teams.
Our people aim to build long-term partnerships with customers along the value chain. We have a deep understanding of our customers’ needs and help create value from untapped opportunities with quality and sustainability driving us.
InnoCore Pharmaceuticals
Bronze Sponsor
InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of long acting and minimally invasive drug delivery products for the treatment of several (chronic) diseases e.g. oncology, pain, atherosclerosis, macular degeneration, CV, osteoarthritis. Our company is using a biodegradable polymer based platform for complex injectables by making microspheres, in-situ-forming depo's and implant formulations. We support the formulation of small molecules, peptides and proteins (including antibodies) for controlled release delivery from days up to six months.
Pion Inc.
Bronze Sponsor
Pion Inc. provides innovative analytical instruments and services that accelerate drug development and improve product quality. With a focus on solubility, dissolution, and permeability, Pion's solutions help pharmaceutical companies optimize their formulations, reduce development timelines, and enhance drug delivery. Pion Inc is the leading provider of analytical instruments and services that support the development of lifesaving and life-enhancing drugs for drug developers, formulations scientists, and pharmaceutical production. Our cutting-edge analytical technologies and services enable in vitro measurements that provide essential data to improve candidate selection and formulations decisions, while our high-pressure homogenizers ensure material consistency from bench- to production-scale. Pion is headquartered in Massachusetts and has offices in the UK and China. For more information, visit www.pion-inc.com.
Thermo Fisher Scientific
Bronze Sponsor
We enable life scientists to unlock the mysteries of biological complexity with cryo-electron microscopy (Cryo-EM). This invaluable technique provides structural insights for a wide range of intractable targets and has become integral to structure-based design. By enabling structure determinations of proteins and macromolecular complexes in near native states and the characterization of drug delivery systems, cryo-EM provides insights benefitting all stages in drug discovery from target evaluation through process development.
Network & Programme Sponsors
Adare Pharma Solutions
Network & Programme Sponsor
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Our specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactured more than 65 products sold by customers worldwide. Adare operates seven facilities in the US and Europe, with over 750 global employees, offering the regional access, supply chain flexibility, and operational resilience needed to make your next commercialization project a success.
Almac
Network & Programme Sponsor
Operating from state-of-the-art facilities in the UK, US and Europe, Almac Pharma Services is a fully regulatory approved CDMO partnering with global pharmaceutical and biotechnology industries.
With over 55 years' experience, we provide a comprehensive range of tailored solutions and access to a wealth of technical experts to support the delivery of your complex projects.
Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. Our scientists can develop your clinical candidate into an optimum formulation and manufacture oral dose products for all stages of clinical trials.
We specialise in the manufacture & primary packaging of oral dosage forms as well as customised secondary packaging for all drug products including ultra-low temperature drug products.
Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options.
Antares Health Products
Network & Programme Sponsor
Antares is leading supplier of vitamin E TPGS, a powerful tool in the formulation of pharmaceuticals, dietary supplements, personal care, and food and nutrition products. Antares develops additional science based, high-quality, novel, functional ingredients. The Antares Team strives to exceed the standards of quality, technical support and customer service and serves as partner in product innovation.
Vitamin E TPGS combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glycoprotein mediated drug efflux and other mechanisms which reduce first-pass metabolism and facilitate its transport, cell uptake and function. The safety and efficacy of vitamin E TPGS expanded research and development in major areas including mRNA, peptide, and other novel drug categories.
Ardigen S.A
Network & Programme Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Aseptic Technologies
Network & Programme Sponsor
Aseptic Technologies, part of the SKAN Group, is a global leader in aseptic processing solutions, ensuring the highest sterility standards for pharmaceutical, biotech, and healthcare applications. We specialize in advanced fill and finish systems and isolator technologies.
As a trusted partner to pharmaceutical manufacturers, we integrate aseptic processes from R&D to production, offering cutting-edge filling equipment, barrier technologies, and custom single use solutions to enhance efficiency and safety.
With decades of expertise, we provide tailored solutions for parenteral drugs, ATMPs, and high-potency compounds. Our mission is to drive aseptic manufacturing excellence through innovation, customer-centric solutions, and industry-leading standards.
BrainXell
Network & Programme Sponsor
BrainXell provides high-purity, iPSC-derived human neurons and glia for research and development. Utilizing proprietary technology, we generate high-purity, subtype-specific neurons that mature rapidly and are ready for a variety of assays. Multiple neuron subtypes are available from control lines and can be made in custom batches from 50 million to 10 billion neurons from unique iPSC lines.
Cellectricon AB
Network & Programme Sponsor
Cellectricon is a leading provider of neurobiology in vitro research services. With a broad platform for in vitro neurobiology research, we provide outstanding value for our Clients through highly customized services delivering scientific excellence, innovation, and quality of the highest of standards.
Our services span the early discovery process where we help our Clients to obtain novel insights into disease biology and to identify targets and lead compounds with potential to produce first-in-class medicines. Working with us, you will benefit from truly collaborative services where scientific exchange and open communication are prioritized to ensure project success.
Our unique discovery platform combines drug discovery expertise and disease area knowledge with cutting-edge technologies. With the platform, we create complex disease models and assays for functional and morphological screening.
Cellectricon’s services are focused on accelerating target and lead discovery programs in the areas of Peripheral Neuropathies, Neuroinflammation, Neurodegeneration and Neuroplasticity.
.jpg?length=600&name=c8f3ee46-970d-4da4-984f-fe6394fe9ac0-2-5668375logo-Glatt_PS_Mailchimp-header_schmaler-(1).jpg)
Glatt Pharmaceutical Services
Network & Programme Sponsor
Glatt Pharmaceutical Services supports pharmaceutical and biotech companies through every stage of drug product development, from initial formulation design to large-scale commercial manufacturing. With expertise spanning early-stage development, including preclinical and clinical supply production, Glatt ensures seamless scalability while maintaining stringent quality standards. Leveraging advanced technologies like fluidized bed systems, spray granulation, and Wurster coating, Glatt specializes in creating tailored solutions for solubility enhancement, modified release, and other complex drug delivery challenges. Partnering with Glatt means access to end-to-end solutions designed to streamline the path from innovation to market.
InProcess-LSP
Network & Programme Sponsor
InProcess-LSP: Innovators in Process Analytical Technology
Founded in 2014 and headquartered in Oss, the Netherlands, InProcess-LSP has positioned itself as a leading innovator in the field of Process Analytical Technology (PAT). Central to the company’s success is the NanoFlowSizer, a pioneering technology developed to address the complex challenges of nanoparticle characterization in dynamic systems.
The NanoFlowSizer represents a significant advancement in nanoparticle measurement, utilizing a non-invasive optical approach for real-time size characterization. This unique instrumentation enables continuous, in-flow analysis of turbid nanosuspensions with unprecedented speed and accuracy, eliminating the need for sample preparation. Its ability to measure particle size and size distribution in highly concentrated and dynamic systems sets it apart in the field of nanoparticle analysis.
Johnson Matthey
Network & Programme Sponsor
Johnson Matthey is a global leader in sustainable technologies. We apply cutting-edge science to create solutions with our customers that make the world cleaner and healthier. As a technology-led organisation, we share the pharmaceutical industry’s passion for R&D and innovation. Our deep expertise in catalysis and engineering has contributed to the synthesis of over a third of the small molecule drugs approved by the US FDA in recent years. Through our market-leading range of catalysts and technical services, we help customers identify optimal catalytic solutions early in development. Our support spans from early research through to commercial manufacture, enabling more efficient, scalable, and sustainable pharmaceutical processes from the outset.
Magnitude Biosciences
Network & Programme Sponsor
Magnitude Biosciences is a specialist Contract Research Organisation (CRO) accelerating R&D pipelines across the pharmaceutical, biotechnology, and nutraceutical industries.
Using the microscopic worm C. elegans as a powerful and scalable in vivo model, our patented WormGazer® technology delivers cost-effective, reproducible health insights. These data help clients make better-informed decisions, strengthen scientific claims, and de-risk the path to clinical trials.
NextPharma Goettingen
Network & Programme Sponsor
NextPharma is a leading European pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with a current footprint spanning five sites in Germany, two in France, one in the UK, one in Finland and one in Norway, and with healthcare logistics services in the DACH region. NextPharma supplies products globally, with eight of its ten sites FDA-approved. With expertise in solids, semi solids and non-sterile and sterile liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, capsules, granules, powders, pellets, gels, creams, sprays and syrups and a wide range of packaging solutions including blow-fill-seal, blisters, bottles, sachets, stick packs and tubes.
With the acquisition of two former Lonza sites in 2021 (Ploërmel, France and Edinburgh, UK), we added to our services lipid-based formulations as soft gel and Liquid-filled hard-shell for pharmaceutical, high potent, hormonal, and nutritional products. The site in Asker (Norway) was acquired in 2023 from Takeda and specialises in chewable tablets.
Nikon Europe B.V
Network & Programme Sponsor
Nikon BioImaging Labs provide contract research services for microscope-based imaging and analysis to the biotech, pharma, and larger research communities. Each lab's full-service capabilities include access to cutting-edge microscopy instrumentation and software, but also the services of expert biologists and microscopists, who are available to provide quality cell culture, sample preparation, data acquisition, and data analysis services.
Hamamatsu Photonics products and technology include optical sensors, light sources, and systems that use these components. They are applied to various new technologies and devices to support people’s lives and help realize a more comfortable and prosperous society. Hamamatsu products are widely used for state-of-the-art medical equipment, test and inspection systems, microscopes that reveal the functions of cells, and giant telescopes that explore the mysteries of the universe.
.png?length=600&name=86519b3d-ae0b-4b81-8d80-029ef5c96390-2-5668375logo-Nuclera_Logo_Principal_Blue-(3).png){kind=logo}
Nuclera
Network & Programme Sponsor
Nuclera is the pioneer in bringing rapid protein prototyping to the benchtop. We make proteins accessible through eProtein DiscoveryTM.
Through our technology, we accelerate breakthrough improvements in human health and empower life science researchers with easy access to target proteins.
Onyx Scientific Limited
Network & Programme Sponsor
Onyx Scientific is the CDMO division of Ipca Laboratories, offering small molecule drug substance development and manufacturing services. Our MHRA-licensed sites in the UK offer early development of candidate APIs and manufacturing for clinical phases through to commercial supply. Dedicated solid-state and analytical chemistry teams expedite development activities at Onyx but are also available to provide full-service outsourced projects to complement or support your in-house campaigns. With a wealth of early development experience and success, our pragmatic, fit-for-purpose approach focuses on rapid process development and a view to future GMP campaigns. Where required, scale-up through Phase II towards commercial manufacture is retained either at Onyx or within the Group through transfer to our sister sites and colleagues in the USA and India.
Pelago Bioscience AB
Network & Programme Sponsor
At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage. Unlike traditional methods, CETSA allows us to assess drug-target interactions in physiologically relevant, unmodified cellular environments—so you can be confident that what you see in cells, you will also see in patients.
Our services rest on four pillars:
1. Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks.
2. Fast & Early Confidence: We deliver actionable insights in just 4-10 weeks, eliminating unnecessary complexities so you can make decisions faster.
3. Insights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs.
4. Extended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals.
With Pelago, you gain more than just data;you gain a trusted partner in your discovery journey.
Selvita S.A.
Network & Programme Sponsor
Selvita is one of the leading preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.
Selvita provides comprehensive solutions supporting Clients and their drug discovery projects, across a broad range of therapeutic areas, specializing in infectious diseases, inflammation, fibrosis, and oncology. The Company offers a range of stand-alone or fully integrated drug discovery and development solutions spanning the entire value chain from early drug discovery to preclinical development, both for small molecules and therapeutic antibodies. On top of that, Selvita also offers analytical support for drug development and contract testing studies.
Selvita, established in 2007, operates globally with over 900 highly qualified employees, of which over 40% hold a PhD degree. The Company's research sites are in Krakow (HQ), Poznan and Wroclaw Poland, and Zagreb, Croatia. The international offices are located in Cambridge, MA, and San Francisco Bay Area, in the U.S., as well as in Cambridge, UK.
Seppic S.A. - Établissement de Paris
Network & Programme Sponsor
Subsidiary of the Air Liquide Group since 1986, company of Air Liquide Healthcare, Seppic develops, manufactures and markets unique ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products.
As expert in surfactants, polymers and formulation, Seppic offers pharmaceutical excipients adapted to oral, topical and parenteral routes of administration.
Seppic’s parenteral excipients portfolio includes MONTANE™ PPI, a range of emulsifiers, and MONTANOX™ PPI, a range of solubilizers, providing formulators with high quality surfactants to ensure the most stable injectable formulations. Last year we launched MontanoxTM 20 HPB, our new non-ionic polysorbate with an improved formula dedicated to biological applications.
Seppic surfactants comply with Good Manufacturing Practices (GMP Part II) and the current most important pharmacopoeias in the world (EP, USP-NF, JP/JPE and ChP), helping target multiple markets with one single range.
Trajan Scientific & Medical
Network & Programme Sponsor
Trajan Scientific and Medical are proud to be a part of Discovery & Development Europe 2025. Visit booth 38, meet our team of experts and discuss how Trajan's advanced automation solutions can help you increase throughput, enhance precision, improve reproducibility, and accelerate discovery in your workflows.
Start-Ups
o At Lucid Genomics, we are pioneering the future of genomic insights by harnessing the power of advanced artificial intelligence. Our mission is to decode the full potential of the human genome, with unprecedented precision and accuracy.
By bridging cutting-edge AI technology with genomic science, we empower users to unlock new discoveries, accelerate personalized medicine, and shape a healthier future.
The Lucid platform
+ covers 100% of the genome screened
+ unlocks cohort analysis
+ reduces false-positive mutations by 87%
+ detects SVs, SNVs and TRs
Synthelis Biotech is a French Life Sciences company based in Grenoble, specializing in cell-free protein synthesis and bioluminescence. Founded by experts in synthetic biology and protein engineering, the company has developed a proprietary cell-free system that enables rapid and efficient expression of proteins, including complex or challenging targets such as membrane proteins and toxins.
With over a decade of experience, Synthelis offers ready-to-use kits, bioluminescent substrates, an AI-powered High Throughput Expression Platform, and customized development services. These solutions support researchers and industry players across the pharmaceutical, biotech, cosmetic, agro, and academic sectors, helping accelerate the path from research to proof-of-concept and product development.
The company also drives innovation in vaccine development, drug screening, and structural biology. Its Hikarazine line of bioluminescent pro-substrates delivers exceptional signal intensity for high-sensitivity assays, enhancing its cutting-edge product portfolio.
As the official French distributor of Berthold Technologies, Synthelis complements its offering with high-performance plate readers and detection systems.
Known for its scientific rigor, flexibility, and client-focused approach, Synthelis makes complex protein production more accessible, efficient, and customizable.
At Synthelis Biotech, the mission is clear: "Biology at speed"—empowering clients to accelerate discovery and innovation with reliable, high-performance solutions.
Bio- Orbit
Start Up Zone
BioOrbit Ltd is a pioneering UK-based biotech CDMO developing the world’s first scalable platform for the crystallisation of biologic drugs in microgravity. Founded in 2023, BioOrbit is tackling a critical challenge in pharmaceutical manufacturing: creating high-concentration, low-viscosity biologic formulations suitable for subcutaneous delivery.
The advantages of protein crystallisation in microgravity are well established. In space, the absence of gravity-induced convection and sedimentation allows for the formation of larger, more uniform crystals. This was powerfully demonstrated in NASA’s landmark study on pembrolizumab (Keytruda), which showed significantly improved crystal quality in low Earth orbit. While this validated the scientific potential, a commercially scalable solution has remained out of reach—until now.
By combining rapid advancements in affordable launch, re-entry technologies, and emerging space infrastructure with BioOrbit’s proprietary crystallisation platform, orbital biomanufacturing is now commercially viable. BioOrbit’s autonomous hardware enables continuous production at scale, from grams to hundreds of kilograms annually.
This breakthrough unlocks the potential for subcutaneous delivery of complex biologics—making treatment faster, less invasive, and more accessible. With two in-orbit demonstration missions scheduled for 2025, BioOrbit is positioned to lead the next era of pharmaceutical innovation as the world’s first CDMO dedicated to in-space drug manufacturing.
Cortex Discovery
Start Up Zone
Cortex Discovery GmbH, founded in 2021 and headquartered in Regensburg, Germany, is a pioneering biotech company specializing in AI-driven preclinical drug discovery. Their proprietary deep learning platform, trained on over 750 million data points across 2.5 million molecules, predicts therapeutic effects, off-target interactions, and pharmacological properties with accuracy comparable to experimental methods.
Cortex's technology has demonstrated success in identifying compounds with antiviral activity against SARS-CoV-2 and HIV-1, as well as cancer growth inhibitors, all validated through laboratory collaborations. Their services encompass virtual high-throughput screening, ADMET profiling, off-target prediction, and de novo compound design, enabling a streamlined transition from hit discovery to lead optimization.
Additionally, Cortex Discovery is developing a next-generation molecular docking technology that integrates deep learning with quantum molecular simulations, significantly accelerating the exploration of new drug targets. The company is also advancing a pipeline focused on longevity and age-related disorders, including the development of AI-discovered compounds proven to extend lifespan in whole organisms.
Cortex Discovery offers both service-based and milestone-driven collaboration models and is actively seeking partnerships with academic and industry entities to further validate and expand its innovative drug discovery approaches.
Luo Automation
Start Up Zone
At Luo Automation, we transform the visual inspection of small parenteral batches by making automation accessible. Our VI-Assist line replaces traditional manual and semi-automated inspection techniques, offering improvements in speed, quality, and cost-efficiency. We believe that technology can meaningfully enhance manual operations by relieving staff of repetitive, labour-intensive tasks while improving product quality. Central to all VI-Assist models is our patented Vision Station, a compact modular unit that performs the full visual inspection process for syringes, ampoules, and vials. Fully compliant with GAMP5, FDA 21 CFR Part 11, and current European and U.S. Pharmacopoeia validation standards, VI-Assist systems offer inspection speeds ranging from 100 to 1200 units per hour, allowing one machine to replace multiple manual operators. Our inspection models are powered by advanced Machine Learning and Artificial Intelligence, enabling faster deployment and requiring smaller sample sets than conventional solutions. Flexibility is built in; format changeovers take less than 15 minutes, and our intuitive, CE-compliant interface ensures easy operation. Thanks to their compact, plug-and-play designs, VI-Assist machines require no special installation to fit into existing GMP environments.
MyxoTech
Start Up Zone
As the pharmaceutical industry continues to progress, it paradoxically needs to revisit the most ancient source for drug leads – nature. While it is historically prolific in drug development, the industry transitioned to other discovery modalities over the last few decades. However, nature's potential never changed. With the advent of new thinking within the industry, a wider range of small molecule complexity sourced from nature will be essential for next generation products.
MyxoTech offers exclusive access to a pool of novel chemical diversity with already proven pharmaceutical value sourced from a group of organisms called myxobacteria. Due to the challenge of growing these microbes in the lab, MyxoTech effectively makes available microbial dark matter chemistry to pharma. With limited pharmaceutical effort in developing this chemistry, there have already been three metabolite scaffolds to reach clinical trials, including FDA approved breast cancer drug ixabepilone. When comparing the physicochemical properties of the 500+ known myxobacterial metabolites to launched drugs, they fall within similar physicochemical ranges across multiple properties. However, myxobacterial metabolites have a more distributed molecular weight distribution corresponding to a more distributed range of complexity.
MyxoTech serves as an outsourced natural product discovery and development pipeline adaptable to the needs of industry clients. We provide downstream services, including production yield optimization, to ensure smooth transition from hit to lead to candidate selection.
Nature is ready to re-emerge in pharma and MyxoTech is primed to offer new natural chemical space for those seeking novel small molecule diversity.
Oncosyne
Start Up Zone
Oncosyne is a clinical-stage biotechnology company that develops tumoroid drug screening for precision medicine and drug development.
For precision medicine, its first diagnostic test targets colorectal cancer test and is being validated in a randomized controlled trial starting this summer. For pancreatic cancer, performance is currently being tested in an ongoing observational trial.
For drug development, Oncosyne's rapid turn-around combined with screening at scale allows for a timely and reliable pre-clinical assessment. Through state-of-the-art lead candidate selection and rational patient-selection, this can significantly accelerate and de-risk drug development. For a pilot partner, data from Oncosyne’s iCAN platform has already been pivotal in initiating a phase 1b/2 clinical study.
Oncosyne is seeking partners with cancer-targeting drug candidates with potential activity in colorectal and pancreatic cancer.
SynSilico B.V
Start Up Zone
SynSilico® was established in 2024 as an AI-based service company to support discoveries and developments of pharma customers. As a joint venture of Genzai and InnoSyn we combine our parent companies strength in AI and Life Sciences. Our first three service platforms are focussing on the needs of our customers to speed up drug discovery and development:
1) SynSilico Optimizer: an easy to use web-based Bayesian Optimization tool which guides any optimization by maximizing learnings from previous experiments. This leads to less and better experiments, more insights and therefore faster and less expensive outcomes. Typical applications are found in formulation and process optimizations.
2) Small Molecule and Enzyme Discovery: a computational pipeline which tests any molecular structure against protein/receptor/enzyme target for their binding efficiency in high-throughput (millions of dockings). In addition, Molecular Dynamic simulations are used to improve precision on binding energy calculations for identified best hits (inhibitors or protein targets).
3) Innobodies™ Design: a humanized single chain antibody design platform combining generative AI, molecular dynamics and efficient microbial expression technology for fast development of biopharma leads against any given customer target protein. This platform can also be used to design custom made binders for protein purification tasks.
Further information will be provided during our Pitch in the Innovation and Collaboration track, or at the SynSilico Booth 10. You can also visit us at www.synsilico.com or contact oliver.may@synsilico.com to schedule a meeting after the show.
